Unitika (3103) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
10 Nov, 2026Executive summary
H1 FY2027 revenue fell 21.3% YoY to ¥48.905bn, reflecting prior-year business exits; operating profit rose 39.7% to ¥7.887bn and net income was ¥7.457bn versus a ¥3.487bn loss.
Higher-value product sales, pricing revisions, cost reductions and strong electronic-material demand supported improved profitability; full-year guidance was raised.
Financial highlights
Revenue was ¥48.905bn, down 21.3% YoY; operating profit was ¥7.887bn, up 39.7%, and ordinary profit was ¥7.622bn, up 57.9%.
Net income attributable to parent shareholders was ¥7.457bn, versus a ¥3.487bn loss in H1 FY2026; EPS was ¥129.34 versus a loss per share of ¥60.49.
Extraordinary restructuring costs fell to ¥1.444bn from ¥7.825bn YoY, contributing to the return to net profit.
Outlook and guidance
FY2027 guidance was raised: revenue ¥94bn, operating profit ¥13bn, ordinary profit ¥12bn and net income ¥11bn; EPS guidance is ¥184.42.
Revised guidance exceeds prior estimates by ¥10bn revenue, ¥5bn operating profit, ¥5.5bn ordinary profit and ¥6bn net income; increases of 11.9%, 62.5%, 84.6% and 120.0%, respectively.
Higher-value product expansion, pricing and cost measures, portfolio reviews, and sustained electronic-material demand underpin the revision; actual results may differ due to multiple factors.
Latest events from Unitika
- Despite lower sales, profits soared in Q1 FY2027 on restructuring and cost discipline.3103
Q1 2027 - Operating profit soared 80.3% year-over-year despite a 6.2% revenue decline.3103
Q4 2026 - Profit and margins surged on restructuring and asset sales, with a strong outlook for earnings.3103
Q3 2026 - Operating profit surged on cost cuts and restructuring, but special losses led to a net loss.3103
Q2 2026 - Operating profit returned to positive, but a major impairment loss drove a significant net loss.3103
Q2 2025 - Strong profit recovery and higher sales, with Q2 outlook raised amid persistent cost risks.3103
Q1 2025 - Operating profit rebounded, but restructuring costs drove a large net loss and no dividend was paid.3103
Q4 2025 - Sales and operating profit rebounded, but a major impairment loss drove a steep net loss.3103
Q3 2025